Nintedanib as a strategy to prevent bronchopulmonary dysplasia: dosing and tim(-ing) is of the essence
Crossref DOI link: https://doi.org/10.1038/s41390-024-03713-3
Published Online: 2024-11-11
Published Print: 2025-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mathias, Maxwell M.
Ganguly, Abhrajit
Tipple, Trent E. https://orcid.org/0000-0002-5156-4282
Text and Data Mining valid from 2024-11-11
Version of Record valid from 2024-11-11
Article History
Received: 14 October 2024
Accepted: 21 October 2024
First Online: 11 November 2024
Competing interests
: The authors declare no competing interests.